The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy

Clinical Nuclear Medicine

Volumn 25, Issue 3, 2000, Pages 193-196

  Yüksel, Doǧangün ^a   Ilgan, Seyfettin ^b   Arslan, Nuri ^b   Uǧur, Ömer ^c   Oztürk, Emel ^b   Bayhan, Hikmet ^b  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Classical bone scan; Pentavalent Tc 99m DMSA; Superscan; Tc 99m MDP

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; SUCCIMER TC 99M;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BONE METASTASIS; BONE SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; MALE; METABOLIC BONE DISEASE; RADIODIAGNOSIS;

ADULT; AGED; BONE AND BONES; BONE DISEASES, METABOLIC; BONE NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 0343920705     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200003000-00008     Document Type: Article

References (25)

1. Constable AR, Cranage RW: Recognition of the superscan in prostatic bone scintigraphy. Br J Radiol 54:122, 1981.
2. Kim SE, Kim DY, Lee DS, et al: Absent or faint renal uptake on bone scan - Etiology and significance in metastatic bone disease. Clin Nucl Med 16:545, 1991.
3. Ohta H, Yamamoto K, Endo K, et al: A new imaging agent in medullary carcinoma of the thyroid. J Nucl Med 25:323, 1984.
4. Ohta H, Endo K, Fujita T, et al: Imaging of head and neck tumors with technetium (V) 99m DMSA a new tumor-seeking agent. Clin Nucl Med 10:855, 1985.
5. Watkinson JC, Lacers CR, Mistry R, et al: Technetium-99m(V) dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma experience in imaging. J Nucl Med 30:174, 1989.
6. Kao CH, Wang SJ, Wey SP, et al: Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs. Eur J Nucl Med 19:890, 1992.
7. Kobayashi H, Sakahara H, Hosono M, et al: Soft-tissue tumors: Diagnosis with 99mTc(V)-dimercaptosuccinic acid scintigraphy. Radiology 190:277, 1994.
8. Hirano T, Otake H, Shibasaki T, Tamura M, Endo K: Differantiating histologic malignancy of primary brain tumours: Pentavalent technetium-99m DMSA. J Nucl Med 38:20, 1997.
9. Kobayashi H, Sakahara H, Itoh T, et al: Technetium-99m(V) dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein. J Nucl Med 34:815, 1993.
10. Ohta H, Endo K, Kanoh T, Konishi J, Kotoura H: Technetium99m(V) DMSA uptake in amyloidosis. J Nucl Med 30:2049, 1989.
11. Jeghers O, Puttemans N, Urbain D, Ham HR: Technetium-99m DMSA uptake by metastatic carcinoma of the prostate. J Nucl Med 27:1223, 1986.
12. Kashyap R, Babbar A, Sahai I, et al: Tc-99m(V) DMSA imaging a new approach to studying metastases from breast carcinoma. Clin Nucl Med 17:119, 1992.
13. Lam ASK, Kettle AG, O'Doherty MJ, et al: Pentavalent 99mTc-DMSA imaging in patients with bone metastases. Nucl Med Commun 18:907, 1997.
14. Higuchi T, Hirano T, Inoue T, et al: Pentavalent. Technetium-99m(V) dimercaptosuccinic acid scintigraphy in renal osteodystrophy. J Nucl Med 39:541, 1998.
15. Kobayashi H, Shigeno C, Sakahara H, et al: Three phase 99mTc(V)-DMSA scintigraphy in Paget's disease: An indicator of pamidronate effect. Br J Radiol 70:1056, 1997.
16. Lamki L, Shearer R: Tc-99m DMSA uptake by metastatic carcinoma of the prostate. J Nucl Med 25:733, 1984.
17. Wulfrank D, Schelstraete KH, Small F, et al: Anology between tumor uptake of technetium-99m(V) dimercaptosuccinic acid-(DMSA) and technetium-99m-MDP. Clin Nucl Med 14:58, 1989.
18. Hirano T, Otake H, Yoshida I, Endo K: Primary lung cancer SPECT imaging with 99mTc pentavalent DMSA. J Nucl Med 36:202, 1995.
19. Lam ASK, Puncher MRB, Blower PJ: In vivo and in vitro studies with pentavalent 99mTc-dimercaptosuccinic acid. Eur J Nucl Med 23:1575, 1996.
20. Yokoyama A, Saji H: Tumor diagnosis using radioactivite metal ions and their complexes. In: Siegel H, ed. Metal Ions in Biological Systems, Vol. 10. New York: Marcel Dekker, 1980, pp 313-40.
21. Zimmer AM, Isitman AT, Holmes RA: Enzymatic inhibition of diphosphonate: A proposed mechanism of tissue uptake. J Nucl Med 16:352, 1975.
22. O'Donoghue EPN, Consatble AR, Sherwood T, Stevenson JJ, Chisholm GD: Bone scaning and plasma phosphatases in carcinoma of the prostate. Br J Urol 50:172, 1978.
23. Fitzpatrick JM, Consatble AR, Sherwood T, et al: The assessment of treatment response in carcinoma of the prostate. Br J Urol 50:555, 1978.
24. Watkinson JC, Allen S, Lazarus CR, et al: Pharmacokinetics, biodistiribution and dosimetry of Tc-99m(V)DMSA in human with squamous cell carcinoma. Nucl Med Commun 11:343, 1990.
25. Singh J, Reghebi K, Lazarus CR, et al: Studies on the preparation an isomeric composition of [186Re]-and [188Re]-pentavalent rhenium dimercaptosuccinic acid complex. Nucl Med Commun 14:197, 1993.